Prosecution Insights
Last updated: August 17, 2026

Examiner: GRAY, PHILLIP A

Tech Center 3700 • Art Units: 2841 3763 3767 3783

This examiner grants 74% of resolved cases

Performance Statistics

74.2%
Allow Rate
+4.2% vs TC avg
937
Total Applications
+10.6%
Interview Lift
1462
Avg Prosecution Days
Based on 910 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
32.5%
§102 Novelty
52.7%
§103 Obviousness
12.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18452096 MEANS AND METHODS FOR IMPLANTING CELLS SECRETING A THERAPEUTIC COMPOUND Non-Final OA Roche Diabetes Care, Inc.
18324916 FORKED PHACOEMULSIFICATION NEEDLE Final Rejection Johnson & Johnson Surgical Vision, Inc.
18671327 Non-Disconnectable Luer Lock Non-Final OA Becton Dickinson and Company
18414593 Sensor Assembly and System for Monitoring Push Medication Delivery to Patients From Syringes Non-Final OA Becton, Dickinson and Company
18248031 DELIVERY DEVICE AND COATED NEEDLE OR CANNULA Final Rejection Becton, Dickinson and Company
18231299 CATHETER WITH POLYMER TERMINATION AT TIP SECTION Non-Final OA Neuravi Limited

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month